WVEWave Life Sciences Ltd.

5.290USDMkt Cap: 1.04B $P/E:

Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine…

Key Statistics

Company
Market Cap1.04B $
Enterprise Value587.49M $
Revenue (TTM)65.37M $
Gross Profit-132.05M $
Net Income (TTM)-204.38M $
Revenue/Share0.3480 USD
Last Price5.290 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees317
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINSG9999014716
Valuation
P/E (Trailing)
P/E (Forward)-4.41
PEG
EV/EBITDA-2.74
EV/Revenue8.99
P/S15.83
P/B1.90
EPS (TTM)-1.05
EPS (Forward)-1.19
52W Range
5.26512% of range5.475
52W High5.475 USD
52W Low5.265 USD
Profitability
Gross Margin-202.00%
Oper. Margin-3248.33%
EBITDA Margin0.00%
Profit Margin-478.33%
ROE-39.43%
ROA-32.01%
Growth
Revenue Growth-73.90%
Earnings Growth
Cash Flow & Leverage
Operating CF-187.49M $
CapEx (TTM)718.00K $
FCF Margin-197.00%
FCF Yield-12.35%
Net Debt-447.01M $
Net Debt/EBITDA2.08
Balance Sheet
Debt/Equity0.03
Current Ratio9.99
Quick Ratio9.67
Book Value/Sh2.762 USD
Cash/Share2.490 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)19.06 USD
Upside (mean)+260.3%
Target Range12.00 USD42.00 USD
$12.00+260.3% to mean$42.00
# Analysts16
Ownership
Shares Out.197.05M
Float94.57M
Insiders15.50%
Institutions85.61%
Short Interest
Short Ratio6.6d
Short % Float10.27%
Short % Out.8.32%
Shares Short16.40M
Short (prev mo.)20.90M
Technical
SMA 505.832 (-9.3%)
SMA 2009.462 (-44.1%)
Beta-1.29
S&P 52W Chg21.00%
Avg Vol (30d)2.70M
Avg Vol (10d)3.94M
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)